The Company owns subsidiary companies that are branded and operate together as Sonomed Escalon, with corporate headquarters in Wayne, Pennsylvania and operations in Lake Success, New York, New Berlin, Wisconsin, and Stoneham, Massachusetts. The company operates as a small-cap public firm trading on the over-the-counter market, providing specialized diagnostic and surgical devices to ophthalmology practitioners.
Cyborg Score Rationale
Escalon holds a niche market position in ophthalmic diagnostics with established product lines and subsidiary operations, but faces significant challenges as a micro-cap OTC-traded company with limited market capitalization (~$1.5M as of mid-2026) and modest trading volumes. The company's specialized focus provides competitive moat but also limits growth opportunities.
Top Insights
Focused niche player in ophthalmic diagnostics with established product portfolio including A-Scan, B-Scan, UBM, and Pachymeter devices
OTC-traded micro-cap with extremely limited market capitalization and liquidity, indicative of financial constraints
Multi-site operations across Pennsylvania, New York, Wisconsin, and Massachusetts suggest distributed manufacturing/distribution infrastructure
Long operating history since 1987 provides domain expertise, though limited evidence of recent major innovations or expansion
Named Competitors
Zeiss Diagnostics — Leading provider of ophthalmic imaging and diagnostic devices
Alcon Surgical Products — Major supplier of ophthalmic surgical devices and solutions